A phase II Clinical Study of CP-4055 as second line therapy in patients with advanced colorectal cancer

Update Il y a 4 ans
Reference: EUCTR2006-006766-41

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To evaluate the objective tumour response in patients with advanced colorectal cancer when treated with CP-4055 for infusion D1-5/4w.


Inclusion criteria

  • A phase II clinical study of ELACYT as second line therapy in patients with advanced colorectal cancer

Links